Live Breaking News & Updates on Cardiovascular Age

Stay updated with breaking news from Cardiovascular age. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Peripartum cardiomyopathy is associated with placental senescence

Scientists at Massachusetts General Hospital have linked the risk of heart failure during pregnancy and senescence proteins produced by placental aging, which could clarify how peripartum cardiomyopathy (PPCM) is triggered and opens the door to the development of cardiac function therapies in late pregnancy. ....

United States , Massachusetts General Hospital , Bioworld Science , Peripartum Cardiomyopathy , Heart Failure , Neonatal Pediatrics ,

Survey Results Reveal Potential Factors Slowing the Decline in Cardiovascular Mortality Rate

Research indicated that worsened glycemic, blood pressure, and obesity control, as well as increased alcohol consumption, leveled lipid control, and persistent socioeconomic disparities may have contributed to the decelerated cardiovascular mortality decline in recent years. ....

United States , National Health , Nutrition Examination , Journal Of The American Heart Association , American Heart Association , Cholesterol Treatment Trialist Collaborators , Hispanic Black , Hispanic White ,

Ultra-processed: Five foods you should avoid to protect heart health

Two years ago, the British Heart Foundation declared the country was in “the grip of the worst heart care crisis in living memory” as 39,000 people in. ....

United Kingdom , Jeff Siepman , Neil Srinivasan , British Heart Foundation , Red Bull , United Kingdom Heart Clinic ,

J&J paces interventional cardio market with $13B Shockwave buy

Med-tech powerhouse Johnson & Johnson made a bold bid to bolster its interventional cardiology holdings with the news on April 5 that it is acquiring Shockwave Medical Inc. for approximately $13.1 billion including cash acquired. The $335 per share cash price represents a more than 5% premium to Shockwave’s (Nasdaq: SWAV) April 4 closing price and a more than 17% premium to the stock price prior to the Wall Street Journal report last week about the rumoured deal. ....

Shockwave Medical Inc , Shockwave Medical , Wall Street Journal , Deals Andm Amp A , Bioworld Medtech , Johnson Amp , Shockwave Medical Inc , Coronary Artery Disease , Peripheral Artery Disease , Intravascular Lithotripsy , Laminar Inc , Abiomed Inc ,